Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): Parasitologic and clinical evaluation of different periodicities of treatment

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 5, 1998, Pages 828-831

  Vyungimana, Frederic ^a   Newell, Edwin ^a,b  

^a Onchocerciasis Control Programme   (Burundi)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ARTICLE; BURUNDI; DEPIGMENTATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; HEALTH PROGRAM; HUMAN; LICHENOID; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; ONCHOCERCIASIS; PRURITUS; RASH; SKIN ATROPHY; SKIN EDEMA; SKIN SCAR;

EID: 0031757939     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.828     Document Type: Article

References (12)

1. Newell E, 1995. Les foyers d'onchocercose au Burundi: leur étendue et la population à risque. Ann Soc Belg Med Trop 75: 273-281.
2. Newell ED, Hicuburundi B, Ndimuruvugo N, 1997. Endémicité et manifestations cliniques de l'onchocercose dans la province de Bururi (Burundi). Trop Med Int Health 2: 218-226.
3. Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA, Schulz-Key H, D'Anna SA, Newland HS, Goldsmidt LP, Auer C, Hanson AP, Freeman SV, Reber EW, Williams PN, 1985. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 313: 133-138.
4. Awadzi K, Dadzie KY, Schulz-Key H, Gilles HM, Sulford AJ, Aziz A, 1986. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in Northern Ghana. Ann Trop Med Parasitol 80: 433-442.
5. Buck AA, 1974. Onchocerciasis: Symptomatology, Pathology, Diagnosis. Geneva: World Health Organization.
6. World Health Organization Study Group on the Prevention of Blindness, 1973. World Health Organ Tech Rep Ser 518.
7. Henry MC, Mulumba MP, Lokomba P, Desmet P, 1987. Comparaison de la sensibilité des scarifications et biopsies dermiques pour le diagnostic de l'onchocercose. Ann Soc Belg Med Trop 67: 353-362.
8. Newell E, 1995. Comparaison de trois méthodes de diagnostic parasitologique de l'onchocercose. Ann Soc Belg Med Trop 75: 245-248.
9. Newell ED, 1997. Comparison of the use of skin scarification and skin biopsies to determine the prevalence and intensity of Onchocerca volvulus infection. Ann Trop Med Parasitol 91: 633-642.
10. Moyou Somo R, Ngosso A, Dinga JS, Enyong PA, Fobi G, 1993. A community-based trial of ivermectin for onchocerciasis in the forest of southwestern Cameroon: clinical and parasitologic findings after threetreatments. Am J Trop Med Hyg 48: 9-13.
11. Whitworth JAG, Maude GH, Downham MD, 1996. Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis. Trop Med Int Health 1: 786-793.
12. Greene BM, Dukuly ZD, Muñoz B, White AT, Pacqué M, Taylor HR, 1991. A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis. J Infect Dis 163: 376-380.